Metropolitan Life Insurance Company (MetLife)’s GALENA BIOPHARMA INC COM RXII Stock Holding History

Metropolitan Life Insurance Company (MetLife)’s Portfolio RXII Stock Details RXII Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q3	–	Sell	-152,527	Closed	-$71K	–	2713
2016 Q2	$71K	Buy	+152,527	New	+$71K	﹤0.01%	2625
2016 Q1	–	Sell	-121,805	Closed	-$179K	–	2605
2015 Q4	$179K	Buy	121,805 +19,369	+19%	+$28.5K	﹤0.01%	2333
2015 Q3	$162K	Buy	102,436 +50,503	+97%	+$79.9K	﹤0.01%	2428
2015 Q2	$88K	Sell	51,933 -51,101	-50%	-$86.6K	﹤0.01%	2620
2015 Q1	$143K	Buy	+103,034	New	+$143K	﹤0.01%	2157
2014 Q4	–	Sell	-98,452	Closed	-$203K	–	2737
2014 Q3	$203K	Buy	98,452 +12,643	+15%	+$26.1K	﹤0.01%	2357
2014 Q2	$263K	Buy	85,809 +9,686	+13%	+$29.7K	﹤0.01%	2312
2014 Q1	$190K	Hold	76,123	–	–	﹤0.01%	2497
2013 Q4	$378K	Hold	76,123	–	–	﹤0.01%	2010
2013 Q3	$173K	Buy	76,123 +2,409	+3%	+$5.47K	﹤0.01%	2527
2013 Q2	$164K	Buy	+73,714	New	+$164K	﹤0.01%	2485

Other funds holding RXII

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.14% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.26% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

BIM

BlackRock Investment Management Wilmington, Delaware $86.4B AUM 28.54% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

Metropolitan Life Insurance Company (MetLife)'s RXII Position: Q3 2016 in Review

Metropolitan Life Insurance Company (MetLife) sold out of GALENA BIOPHARMA INC COM (RXII) in Q3 2016, closing a stake of 152,527 shares — an estimated $71K sold.

Metropolitan Life Insurance Company (MetLife) first reported a position in RXII in Q2 2013 and held it in 11 quarters. The position peaked at $378K in Q4 2013. 91 funds tracked by Wall St. Rank hold RXII as of Q3 2016.

Metropolitan Life Insurance Company (MetLife) reported no remaining GALENA BIOPHARMA INC COM position as of Q3 2016 after selling out during the quarter.
Metropolitan Life Insurance Company (MetLife) sold 152,527 GALENA BIOPHARMA INC COM shares in Q3 2016, an estimated $71K.
Metropolitan Life Insurance Company (MetLife) first reported a position in GALENA BIOPHARMA INC COM in Q2 2013 and held it in 11 quarters.
Metropolitan Life Insurance Company (MetLife)'s GALENA BIOPHARMA INC COM position peaked at $378K in Q4 2013.
91 funds tracked by Wall St. Rank held GALENA BIOPHARMA INC COM as of Q3 2016.

Based on Metropolitan Life Insurance Company (MetLife)'s 13F filing for Q3 2016, filed 15 Nov 2016.